Immunohistochemistry (IHC) staining of colon cancer tissue removed from a cohort of 137 patients showed high CD133 expression in 64% of stage I, 28% of stage II, and 54% of stage III tumors (29). The gene discussed is PROM1; the disease is malignant colon neoplasm.